Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Kenneth Zhou"'
Adoptive T cell immunotherapy for medullary thyroid carcinoma targeting GDNF family receptor alpha 4
Autor:
Vijay G. Bhoj, Lucy Li, Kalpana Parvathaneni, Zheng Zhang, Stephen Kacir, Dimitrios Arhontoulis, Kenneth Zhou, Bevin McGettigan-Croce, Selene Nunez-Cruz, Gayathri Gulendran, Alina C. Boesteanu, Laura Johnson, Michael D. Feldman, Enrico Radaelli, Keith Mansfield, MacLean Nasrallah, Rebecca S. Goydel, Haiyong Peng, Christoph Rader, Michael C. Milone, Don L. Siegel
Publikováno v:
Molecular Therapy: Oncolytics, Vol 20, Iss , Pp 387-398 (2021)
Metastatic medullary thyroid cancer (MTC) is a rare but often aggressive thyroid malignancy with a 5-year survival rate of less than 40% and few effective therapeutic options. Adoptive T cell immunotherapy using chimeric antigen receptor (CAR)-modifi
Externí odkaz:
https://doaj.org/article/21295495ac0b4d158ff8bf09829bb9f3
Autor:
Tingting Liu, Kenneth Zhou
Publikováno v:
Journal of Intellectual Property Law & Practice. 16:916-922
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::965799908d2ae2f62009345dac1253fc
https://doi.org/10.1093/jiplp/jpab099
https://doi.org/10.1093/jiplp/jpab099
Autor:
Lester Ross, Kenneth Zhou
Publikováno v:
Journal of Investment Compliance. 22:47-52
Purpose To describe and analyze the implications of the new Measures (the “Measures”) for Cybersecurity Review jointly promulgated on April 27, 2020 by twelve Chinese government departments led by the Cyberspace Administration of China (CAC). Des
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3cbf2f6ad7c76818c06ec19ad573f4c1
https://doi.org/10.1108/joic-10-2020-0039
https://doi.org/10.1108/joic-10-2020-0039
Autor:
Kenneth Zhou
Publikováno v:
Journal of Intellectual Property Law & Practice. 15:442-449
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b989ee1a4662fd55e0e2291ba62ffaa2
https://doi.org/10.1093/jiplp/jpaa053
https://doi.org/10.1093/jiplp/jpaa053
Autor:
Kenneth Zhou, XIAO BAI ZHU
Publikováno v:
European actuarial journal.
This paper proposes a spline mortality model for generating smooth projections of mortality improvement rates. In particular, we follow the two-dimensional cubic B-spline approach developed by Currie et al. (Stat Model 4(4):279-298, 2004), and adopt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8914b8633276839c2f9e9bacc1b00245
https://pubmed.ncbi.nlm.nih.gov/35789761
https://pubmed.ncbi.nlm.nih.gov/35789761
Autor:
Stephanie C. Eisenbarth, Kenneth Zhou
Publikováno v:
Science Immunology. 5
T-bet + memory B cells are a distinct subset that home to the spleen and produce neutralizing antibodies against influenza.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cd1bcb140658b611373b91134498f30
https://doi.org/10.1126/sciimmunol.abd0542
https://doi.org/10.1126/sciimmunol.abd0542
Adoptive T cell immunotherapy for medullary thyroid carcinoma targeting GDNF family receptor alpha 4
Autor:
Selene Nunez-Cruz, Michael Feldman, Kenneth Zhou, Christoph Rader, Haiyong Peng, Stephen Kacir, Keith Mansfield, Alina C. Boesteanu, Zheng Zhang, Enrico Radaelli, MacLean Nasrallah, Bevin McGettigan-Croce, Rebecca S. Goydel, Vijay Bhoj, Don L. Siegel, Michael C. Milone, Kalpana Parvathaneni, Gayathri Gulendran, Dimitrios Arhontoulis, Lucy Z. Li, Laura A. Johnson
Publikováno v:
Molecular Therapy Oncolytics
Molecular Therapy: Oncolytics, Vol 20, Iss, Pp 387-398 (2021)
Molecular Therapy: Oncolytics, Vol 20, Iss, Pp 387-398 (2021)
Metastatic medullary thyroid cancer (MTC) is a rare but often aggressive thyroid malignancy with a 5-year survival rate of less than 40% and few effective therapeutic options. Adoptive T cell immunotherapy using chimeric antigen receptor (CAR)-modifi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::136615ee16ed55eb834ffa1e9b74f952
https://pubmed.ncbi.nlm.nih.gov/33614919
https://pubmed.ncbi.nlm.nih.gov/33614919
Autor:
Selene Nunez-Cruz, Michael Feldman, Keith Mansfield, Vijay Bhoj, Haiyong Peng, Christoph Rader, Kenneth Zhou, Michael C. Milone, Don L. Siegel, Dimitrios Arhontoulis
Publikováno v:
Cancer Research. 76:2295-2295
Metastatic medullary thyroid cancer (MTC) is a rare, but often aggressive, thyroid malignancy with a 5-year survival rate of 28% and few effective therapeutic options. Adoptive T-cell immunotherapy using chimeric antigen receptor (CAR)-modified T cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::74be29d6c9f1ba0e59d2b66bf8c3447f
https://doi.org/10.1158/1538-7445.am2016-2295
https://doi.org/10.1158/1538-7445.am2016-2295